230 related articles for article (PubMed ID: 28940998)
1. More than just side-effects: The role of clinical and psychosocial factors in non-adherence to tamoxifen.
Moon Z; Moss-Morris R; Hunter MS; Hughes LD
Br J Health Psychol; 2017 Nov; 22(4):998-1018. PubMed ID: 28940998
[TBL] [Abstract][Full Text] [Related]
2. Understanding tamoxifen adherence in women with breast cancer: A qualitative study.
Moon Z; Moss-Morris R; Hunter MS; Hughes LD
Br J Health Psychol; 2017 Nov; 22(4):978-997. PubMed ID: 28850763
[TBL] [Abstract][Full Text] [Related]
3. Measuring illness representations in breast cancer survivors (BCS) prescribed tamoxifen: Modification and validation of the Revised Illness Perceptions Questionnaire (IPQ-BCS).
Moon Z; Moss-Morris R; Hunter MS; Hughes LD
Psychol Health; 2017 Apr; 32(4):439-458. PubMed ID: 28052692
[TBL] [Abstract][Full Text] [Related]
4. Nonadherence to tamoxifen in breast cancer survivors: A 12 month longitudinal analysis.
Moon Z; Moss-Morris R; Hunter MS; Norton S; Hughes LD
Health Psychol; 2019 Oct; 38(10):888-899. PubMed ID: 31343218
[TBL] [Abstract][Full Text] [Related]
5. Medication taking behaviors among breast cancer patients on adjuvant endocrine therapy.
Kimmick G; Edmond SN; Bosworth HB; Peppercorn J; Marcom PK; Blackwell K; Keefe FJ; Shelby RA
Breast; 2015 Oct; 24(5):630-6. PubMed ID: 26189978
[TBL] [Abstract][Full Text] [Related]
6. Factors associated with intentional and unintentional non-adherence to adjuvant endocrine therapy following breast cancer.
Brett J; Fenlon D; Boulton M; Hulbert-Williams NJ; Walter FM; Donnelly P; Lavery B; Morgan A; Morris C; Watson E
Eur J Cancer Care (Engl); 2018 Jan; 27(1):. PubMed ID: 27901302
[TBL] [Abstract][Full Text] [Related]
7. Development of a self-management intervention to improve tamoxifen adherence in breast cancer survivors using an Intervention Mapping framework.
Moon Z; Moss-Morris R; Hunter MS; Hughes LD
Support Care Cancer; 2021 Jun; 29(6):3329-3338. PubMed ID: 33118106
[TBL] [Abstract][Full Text] [Related]
8. Unintentional and intentional non-adherence to immunosuppressive medications in renal transplant recipients.
Griva K; Neo HLM; Vathsala A
Int J Clin Pharm; 2018 Oct; 40(5):1234-1241. PubMed ID: 29872960
[TBL] [Abstract][Full Text] [Related]
9. The impact of symptom clusters on endocrine therapy adherence in patients with breast cancer.
Agnew S; Crawford M; MacPherson I; Shiramizu V; Fleming L
Breast; 2024 Jun; 75():103731. PubMed ID: 38599048
[TBL] [Abstract][Full Text] [Related]
10. Comparing patient dissatisfaction and rational judgment in intentional medication non-adherence versus unintentional non-adherence.
Iihara N; Nishio T; Okura M; Anzai H; Kagawa M; Houchi H; Kirino Y
J Clin Pharm Ther; 2014 Feb; 39(1):45-52. PubMed ID: 24106917
[TBL] [Abstract][Full Text] [Related]
11. Intentional- but not Unintentional Medication Non-adherence was Related with Beliefs about Medicines Among a Multi-Ethnic Sample of People with HIV.
Castelan A; Nellen JF; van der Valk M; Nieuwkerk PT
AIDS Behav; 2023 Apr; 27(4):1045-1054. PubMed ID: 36056998
[TBL] [Abstract][Full Text] [Related]
12. Understanding Breast Cancer Survivors' Beliefs and Concerns About Adjuvant Hormonal Therapy: Promoting Adherence.
Hurtado-de-Mendoza A; Jensen RE; Jennings Y; Sheppard VB
J Cancer Educ; 2018 Apr; 33(2):436-439. PubMed ID: 28205022
[TBL] [Abstract][Full Text] [Related]
13. Perceptions, Attributions, and Emotions Toward Endocrine Therapy in Young Women with Breast Cancer.
Walker HE; Rosenberg SM; Stanton AL; Petrie KJ; Partridge AH
J Adolesc Young Adult Oncol; 2016 Mar; 5(1):16-23. PubMed ID: 26812461
[TBL] [Abstract][Full Text] [Related]
14. Women's experiences of hormonal therapy for breast cancer: exploring influences on medication-taking behaviour.
Cahir C; Dombrowski SU; Kelly CM; Kennedy MJ; Bennett K; Sharp L
Support Care Cancer; 2015 Nov; 23(11):3115-30. PubMed ID: 25744290
[TBL] [Abstract][Full Text] [Related]
15. Medication beliefs, treatment complexity, and non-adherence to different drug classes in patients with type 2 diabetes.
de Vries ST; Keers JC; Visser R; de Zeeuw D; Haaijer-Ruskamp FM; Voorham J; Denig P
J Psychosom Res; 2014 Feb; 76(2):134-8. PubMed ID: 24439689
[TBL] [Abstract][Full Text] [Related]
16. The value of high adherence to tamoxifen in women with breast cancer: a community-based cohort study.
McCowan C; Wang S; Thompson AM; Makubate B; Petrie DJ
Br J Cancer; 2013 Sep; 109(5):1172-80. PubMed ID: 23949153
[TBL] [Abstract][Full Text] [Related]
17. Symptoms and QOL as Predictors of Chemoprevention Adherence in NRG Oncology/NSABP Trial P-1.
Land SR; Walcott FL; Liu Q; Wickerham DL; Costantino JP; Ganz PA
J Natl Cancer Inst; 2016 Apr; 108(4):. PubMed ID: 26615179
[TBL] [Abstract][Full Text] [Related]
18. Unintentional non-adherence to chronic prescription medications: how unintentional is it really?
Gadkari AS; McHorney CA
BMC Health Serv Res; 2012 Jun; 12():98. PubMed ID: 22510235
[TBL] [Abstract][Full Text] [Related]
19. Behavioral Interventions to Enhance Adherence to Hormone Therapy in Breast Cancer Survivors: A Systematic Literature Review.
Hurtado-de-Mendoza A; Cabling ML; Lobo T; Dash C; Sheppard VB
Clin Breast Cancer; 2016 Aug; 16(4):247-255.e3. PubMed ID: 27133733
[TBL] [Abstract][Full Text] [Related]
20. Adherence and discontinuation of adjuvant hormonal therapy in breast cancer patients: a population-based study.
Wigertz A; Ahlgren J; Holmqvist M; Fornander T; Adolfsson J; Lindman H; Bergkvist L; Lambe M
Breast Cancer Res Treat; 2012 May; 133(1):367-73. PubMed ID: 22286315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
